FDA weighs improving medication guides
The agency is especially interested in getting views from consumers, pharmacies, manufacturers, wholesalers, and researchers.
The FDA is holding a hearing on medication guides. The goal is to find ways to improve the development, distribution, comprehensibility, and accessibility of these documents, which provide drug risk information to patients. The hearing will be held on June 12 to 13 at the National Transportation and Safety Board Boardroom and Conference Center in Washington, D.C. The agency is especially interested in getting views from consumers, pharmacies, manufacturers, wholesalers, and researchers. For more information, refer to the notice in the April 9 Federal Register or go to
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
